CD6

CD6

CD6 Overview

Molecule Name
T-cell differentiation antigen CD6
Synonyms
CD6,TP120,T12
Drug Development Progress
Drugs in Clinical Trials1
Approved Drugs1
Highest Development StageApproved
Target Synonym
T12,CD6,CD6 Molecule,TP120,T-Cell Differentiation Antigen CD6,CD6 Antigen
Background
CD6 (Cluster of Differentiation 6) is a cell surface glycoprotein that is involved in T cell activation and a member of the scavenger receptor cysteine rich protein superfamily (SRCRSF). CD6 is expressed at low levels on immature thymocytes and at high levels on mature thymocytes. The majority of peripheral blood T cells, a subset of B cells, and a subset of neuronal cells express CD6. CD6 appears to play a role as both a costimulatory molecule in T cell activation and as an adhesion receptor. Studies demonstrating a mitogenic effect for T cells with some CD6 specific monoclonal antibodies, in conjunction with either accessory cells or PMA and anti-CD2 mAb, support the concept of CD6 as a co stimulatory molecule.

CD6 Product List

Species
  • Cynomolgus(3)
  • Human(3)
Tag
  • Fc Tag & Avi Tag(2)
  • His Tag(2)
  • His Tag & Avi Tag(2)
Host
  • HEK293(6)
Conjugate
  • Biotin-labeled(4)
  • Unconjugated(2)
Grade
  • RUO(6)
Low Endotoxin
  • No(6)
MoleculeCat. No.Product NameSpeciesHostStructurePurityActivitySize&PriceAdd to Cart
CD6
HOTAvitag
CD6-H82E3
Biotinylated Human CD6 Protein, His,Avitag™ (MALS verified)
Human
HEK293
MALSSDS-PAGE
ELISA

$360.00

25ug
CD6
Human CD6 / TP120 Protein, His Tag
Human
HEK293
SDS-PAGE

$340.00

100ug
CD6
Cynomolgus CD6 Protein, His Tag (MALS verified)
Cynomolgus
HEK293
MALSSDS-PAGE
ELISA

$395.00

100ug
CD6
Avitag
CD6-C82E3
Biotinylated Cynomolgus CD6 Protein, His,Avitag™ (MALS verified)
Cynomolgus
HEK293
MALSSDS-PAGE
ELISA

$360.00

100ug
CD6
Avitag
CD6-C82F3
Biotinylated Cynomolgus CD6 / TP120 Protein, Fc,Avitag™ (MALS verified)
Cynomolgus
HEK293
MALSSDS-PAGE
ELISA

$360.00

25ug
CD6
Avitag
CD6-H82F3
Biotinylated Human CD6 / TP120 Protein, Fc,Avitag™ (MALS verified)
Human
HEK293
MALSSDS-PAGE
ELISA

$360.00

25ug
You Have Viewed 1-6 Of 6 Results
  • 1

Can’t find what you need?

Submit your requirements and our technical
team will help.

Asset Licensing Opportunity
Resources

Clinical Drug Information

English NameResearch CodeHighest Development StageCompanyIndicationClinical Trial
Allogeneic CD6 Chimeric Antigen Receptor T Regulatory Cells therapy (City of Hope Medical Center)Phase 1 ClinicalCity Of Hope National Medical Center
Diabetes Mellitus, Type 1; Graft vs Host Disease; Hemic and Lymphatic Diseases
Details

Marketed Drug Information

English NameResearch CodeHighest Development StageCompanyFirst Brand NameFirst Approved CountryFirst IndicationFirst Approved CompanyFirst Approved DateIndicationClinical Trial
ItolizumabT-1-hT; EQ-001; T-1-h; h-T1; Bmab-600; Bmab600ApprovedCenter Of Molecular ImmunologyAlzumabIndiaPlaque psoriasisBiocon Ltd2013-01-01
Asthma; Coronavirus Disease 2019 (COVID-19); Dermatomyositis; Graft vs Host Disease; Lupus Erythematosus, Cutaneous; Lupus Nephritis; Plaque psoriasis; Psoriasis; Respiratory Distress Syndrome, Adult
Details
Customer Reviews
  • g***t2025-11-28
    We use Human CD16 from AcroBiosystems since many years now for in vitro characterization of antibodies and we are very happy to have well documented certificate to set up our experiments.